Drugs / CSL425
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00940108 | Aug → Oct 2009 | swine influenza | Seqirus | Completed | No outcome recorded |
| Phase 2 | NCT00958243 | Aug → Nov 2009 | influenza | Seqirus | Completed | No outcome recorded |
| Phase 2 | NCT00958126 | Aug → Nov 2009 | influenza | Seqirus | Completed | No outcome recorded |
| Phase 2 | NCT00938639 | Jul → Sep 2009 | swine influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CSL425 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00938639 ↗ |
| Known as | CSL's 2009 H1N1 Influenza Vaccine | “CSL's 2009 H1N1 Influenza Vaccine (CSL425)” NCT00958243 ↗ |
| Modality | Vaccine | “inactivated, split-virus 2009 influenza A(H1N1) vaccine” PMID 20026597 ↗ Dec 2009 |
| Route | Intramuscular | “by intramuscular injection” PMID 19745216 ↗ Sep 2009 |